Media Center Investor Relations Overview Investor News Press Releases Company Statements Media Kit Events Stock Information Stock Quote & Chart Analyst Coverage Ownership Profile Financials SEC Filings Annual Reports Governance Governance Documents Committee Composition Investor Resources Investor FAQs Settlement Information Contact Us Scientific Publications & Presentations Investor Email Alerts Investor contact760-603-2331Email Media contact760-603-4679Email Event Details 2025 American Academy of Allergy Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress Feb 28 - Mar 3, 2025 Supporting Materials Improvements in Quality-of-Life in Patients with HAE Receiving Donidalorsen 175 KB Patient Preferences for Attributes of Prophylactic Treatment in Hereditary Angioedema A Discrete-Choice Experiment 700.1 KB Participant-Reported Ease-of-Use With a Prefilled, Single-Dose, Disposable Autoinjector for the Treatment 406.7 KB The Patient Experience Of Hereditary Angioedema Findings From A Racially Diverse Sample Of Adult Patients 282.2 KB Patient-Reported Injection-Site Pain and Treatment Satisfaction After Switching From Long-Term Prophylaxis 503.2 KB Hereditary Angioedema Disease Control After Switching to Donidalorsen From Prior Long-Term Prophylaxis 504.5 KB Efficacy and Safety of Donidalorsen in Adolescent Patients With Hereditary Angioedema 324.8 KB Correlation between Subjective and Objective Disease Control in Hereditary Angioedema Association between the Angioedema Control Test and Attack Rate 300.1 KB Psychometric Validation of Angioedema Quality-Of-Life Questionnaire in Hereditary Angioedema Results from the OASIS-HAE Study 1.2 MB Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema 326.8 KB Long-Term Prophylaxis for Hereditary Angioedema Real-World Treatment Patterns in Selected US Allergy Clinics 245.9 KB
2025 American Academy of Allergy Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress Feb 28 - Mar 3, 2025 Supporting Materials Improvements in Quality-of-Life in Patients with HAE Receiving Donidalorsen 175 KB Patient Preferences for Attributes of Prophylactic Treatment in Hereditary Angioedema A Discrete-Choice Experiment 700.1 KB Participant-Reported Ease-of-Use With a Prefilled, Single-Dose, Disposable Autoinjector for the Treatment 406.7 KB The Patient Experience Of Hereditary Angioedema Findings From A Racially Diverse Sample Of Adult Patients 282.2 KB Patient-Reported Injection-Site Pain and Treatment Satisfaction After Switching From Long-Term Prophylaxis 503.2 KB Hereditary Angioedema Disease Control After Switching to Donidalorsen From Prior Long-Term Prophylaxis 504.5 KB Efficacy and Safety of Donidalorsen in Adolescent Patients With Hereditary Angioedema 324.8 KB Correlation between Subjective and Objective Disease Control in Hereditary Angioedema Association between the Angioedema Control Test and Attack Rate 300.1 KB Psychometric Validation of Angioedema Quality-Of-Life Questionnaire in Hereditary Angioedema Results from the OASIS-HAE Study 1.2 MB Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema 326.8 KB Long-Term Prophylaxis for Hereditary Angioedema Real-World Treatment Patterns in Selected US Allergy Clinics 245.9 KB
Patient Preferences for Attributes of Prophylactic Treatment in Hereditary Angioedema A Discrete-Choice Experiment 700.1 KB
Participant-Reported Ease-of-Use With a Prefilled, Single-Dose, Disposable Autoinjector for the Treatment 406.7 KB
The Patient Experience Of Hereditary Angioedema Findings From A Racially Diverse Sample Of Adult Patients 282.2 KB
Patient-Reported Injection-Site Pain and Treatment Satisfaction After Switching From Long-Term Prophylaxis 503.2 KB
Hereditary Angioedema Disease Control After Switching to Donidalorsen From Prior Long-Term Prophylaxis 504.5 KB
Correlation between Subjective and Objective Disease Control in Hereditary Angioedema Association between the Angioedema Control Test and Attack Rate 300.1 KB
Psychometric Validation of Angioedema Quality-Of-Life Questionnaire in Hereditary Angioedema Results from the OASIS-HAE Study 1.2 MB
Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema 326.8 KB
Long-Term Prophylaxis for Hereditary Angioedema Real-World Treatment Patterns in Selected US Allergy Clinics 245.9 KB
